The Therapeutic Potential of Small-conductance KCa2 Channels in Neurodegenerative and Psychiatric Diseases

Overview

Journal Expert Opin Ther Targets

Publisher Informa Healthcare

Specialty Pharmacology

Date 2013 Jul 26

PMID 23883298

Citations 26

Authors

Jenny Lam

Nichole Coleman

April Lourdes A Garing

Heike Wulff

Affiliations

Soon will be listed here.

Abstract

Introduction: KCa2 or small-conductance Ca(2+)-activated K(+) channels (SK) are expressed in many areas of the central nervous system where they participate in the regulation of neuronal afterhyperpolarization and excitability, and also serve as negative feedback regulators on the glutamate-NMDA pathway.

Areas Covered: This review focuses on the role of KCa2 channels in learning and memory and their potential as therapeutic targets for Alzheimer's and Parkinson's disease, ataxia, schizophrenia and alcohol dependence.

Expert Opinion: There currently exists relatively solid evidence supporting the use of KCa2 activators for ataxia. Genetic KCa2 channel suppression in deep cerebellar neurons induces ataxia, while KCa2 activators like 1-EBIO, SKA-31 and NS13001 improve motor deficits in mouse models of episodic ataxia (EA) and spinal cerebellar ataxia (SCA). Use of KCa2 activators for ataxia is further supported by a report that riluzole improves ataxia in a small clinical trial. Based on accumulating literature evidence, KCa2 activators further appear attractive for the treatment of alcohol dependence and withdrawal. Regarding Alzheimer's disease, Parkinson's disease and schizophrenia, further research, including long-term studies in disease relevant animal models, will be needed to determine whether KCa2 channels constitute valid targets and whether activators or inhibitors would be needed to positively affect disease outcomes.

Citing Articles

Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.

Qiu Q, Yang M, Gong D, Liang H, Chen T Neural Regen Res. 2024; 20(5):1258-1276.

PMID: 38845230 PMC: 11624876. DOI: 10.4103/NRR.NRR-D-23-01766.

Oxidative stress and ion channels in neurodegenerative diseases.

Orfali R, Alwatban A, Orfali R, Lau L, Chea N, Alotaibi A Front Physiol. 2024; 15:1320086.

PMID: 38348223 PMC: 10859863. DOI: 10.3389/fphys.2024.1320086.

K 2.2 (KCNN2): A physiologically and therapeutically important potassium channel.

Rahman M, Orfali R, Dave N, Lam E, Naguib N, Nam Y J Neurosci Res. 2023; 101(11):1699-1710.

PMID: 37466411 PMC: 10932612. DOI: 10.1002/jnr.25233.

Activation of small conductance Ca -activated K channels suppresses Ca transient and action potential alternans in ventricular myocytes.

Kanaporis G, Blatter L J Physiol. 2022; 601(1):51-67.

PMID: 36426548 PMC: 9878619. DOI: 10.1113/JP283870.

The modulation of potassium channels by estrogens facilitates neuroprotection.

Li X Front Cell Dev Biol. 2022; 10:998009.

PMID: 36393851 PMC: 9643774. DOI: 10.3389/fcell.2022.998009.

References

Stocker M, Krause M, Pedarzani P . An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons. Proc Natl Acad Sci U S A. 1999; 96(8):4662-7. PMC: 16389. DOI: 10.1073/pnas.96.8.4662. View

Steketee J, Kalivas P . Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther. 1990; 254(2):711-9. View

Shakkottai V, Chou C, Oddo S, Sailer C, Knaus H, Gutman G . Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. J Clin Invest. 2004; 113(4):582-90. PMC: 338266. DOI: 10.1172/JCI20216. View

Ren Y, Barnwell L, Alexander J, Lubin F, Adelman J, Pfaffinger P . Regulation of surface localization of the small conductance Ca2+-activated potassium channel, Sk2, through direct phosphorylation by cAMP-dependent protein kinase. J Biol Chem. 2006; 281(17):11769-79. DOI: 10.1074/jbc.M513125200. View

Walter J, Alvina K, Womack M, Chevez C, Khodakhah K . Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci. 2006; 9(3):389-97. DOI: 10.1038/nn1648. View

Williams S, Serafin M, Muhlethaler M, Bernheim L . Distinct contributions of high- and low-voltage-activated calcium currents to afterhyperpolarizations in cholinergic nucleus basalis neurons of the guinea pig. J Neurosci. 1997; 17(19):7307-15. PMC: 6573441. View

Farde L . Brain imaging of schizophrenia--the dopamine hypothesis. Schizophr Res. 1998; 28(2-3):157-62. DOI: 10.1016/s0920-9964(97)00121-7. View

Shepard P, Stump D . Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons. Brain Res. 1999; 817(1-2):104-9. DOI: 10.1016/s0006-8993(98)01231-1. View

Gao Z, Todorov B, Barrett C, van Dorp S, Ferrari M, van den Maagdenberg A . Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice. J Neurosci. 2012; 32(44):15533-46. PMC: 6621567. DOI: 10.1523/JNEUROSCI.2454-12.2012. View

10.

Mulholland P, Becker H, Woodward J, Chandler L . Small conductance calcium-activated potassium type 2 channels regulate alcohol-associated plasticity of glutamatergic synapses. Biol Psychiatry. 2010; 69(7):625-32. PMC: 3103782. DOI: 10.1016/j.biopsych.2010.09.025. View

11.

Allen D, Nakayama S, Kuroiwa M, Nakano T, Palmateer J, Kosaka Y . SK2 channels are neuroprotective for ischemia-induced neuronal cell death. J Cereb Blood Flow Metab. 2011; 31(12):2302-12. PMC: 3323193. DOI: 10.1038/jcbfm.2011.90. View

12.

Messier C, Mourre C, Bontempi B, Sif J, Lazdunski M, Destrade C . Effect of apamin, a toxin that inhibits Ca(2+)-dependent K+ channels, on learning and memory processes. Brain Res. 1991; 551(1-2):322-6. DOI: 10.1016/0006-8993(91)90950-z. View

13.

Sherr J, Myers C, Avila M, Elliott A, Blaxton T, Thaker G . The effects of nicotine on specific eye tracking measures in schizophrenia. Biol Psychiatry. 2002; 52(7):721-8. DOI: 10.1016/s0006-3223(02)01342-2. View

14.

Thun M, Peto R, Lopez A, Monaco J, Henley S, Heath Jr C . Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997; 337(24):1705-14. DOI: 10.1056/NEJM199712113372401. View

15.

Geurts J, Wolswijk G, Bo L, van der Valk P, Polman C, Troost D . Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain. 2003; 126(Pt 8):1755-66. DOI: 10.1093/brain/awg179. View

16.

Murthy S, Teodorescu G, Nijholt I, Dolga A, Grissmer S, Spiess J . Identification and characterization of a novel, shorter isoform of the small conductance Ca2+ -activated K+ channel SK2. J Neurochem. 2008; 106(6):2312-21. DOI: 10.1111/j.1471-4159.2008.05557.x. View

17.

Hashimoto T, Volk D, Eggan S, Mirnics K, Pierri J, Sun Z . Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003; 23(15):6315-26. PMC: 6740534. View

18.

Disterhoft J, Matthew Oh M . Learning, aging and intrinsic neuronal plasticity. Trends Neurosci. 2006; 29(10):587-99. DOI: 10.1016/j.tins.2006.08.005. View

19.

McGrath J, Saha S, Chant D, Welham J . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008; 30:67-76. DOI: 10.1093/epirev/mxn001. View

20.

Conejo-Garcia A, Campos J . Bis-quinolinium cyclophanes: highly potent and selective non-peptidic blockers of the apamin-sensitive Ca2+-activated K+ channel. Curr Med Chem. 2008; 15(13):1305-15. DOI: 10.2174/092986708784534983. View